Microelectrode techniques were used to study isolated canine Purkinje fibers perfused alternately with Tyrode's solution and extracorporeally circulated arterial blood from heparinized donor dogs. Action potential amplitude and resting membrane potential were similar in both perfusates and varied with the potassium concentration of the perfusate. Action potential duration also varied with the potassium concentration of the perfusate, being shorter when potassium concentration was higher. Conduction in free-running Purkinje fibers usually was more rapid in blood than in Tyrode's solution; this difference often was not related to changes in potassium concentration, maximal slope of phase 0, and action potential amplitude. Automaticity was comparable in both perfusates. Because conduction time in isolated tissues differs during perfusion with blood and Tyrode's solution, it would seem that experiments on conduction performed during blood perfusion might reflect in vivo events more closely than results obtained using Tyrode's solution.
• Studies on the electrophysiology and pharmacology of isolated preparations of cardiac tissue usually are performed during perfusion with Tyrode's or other physiological salt solutions. These solutions resemble the extracellular body fluids only in the concentration of certain ions and dextrose. The extent to which the multiple factors present in blood might influence the electrophysiological properties of the cardiac cell membrane has not been determined. Draper and Weidmann (1) used plasma to perfuse isolated preparations of cardiac Purkinje fibers and noted that action potential amplitude decreased as compared to values obtained in Tyrode's solution.
Recently we developed a technique to perfuse isolated preparations of cardiac tissue alternately with Tyrode's solution and arterial blood from a donor animal. This method was used to compare certain electrophysiological properties of canine cardiac Purkinje fibers during perfusion with Tyrode's solution and arterial blood.
Methods
Mongrel dogs weighing 15-25 kg were anesthetized with sodium pentobarbital, 30 mg/kg, iv. A right lateral thoracotomy was performed, and the heart was rapidly removed and placed in cool oxygenated Tyrode's solution containing (in mmoles/liter) NaCl 137, NaHCO 3 12, dextrose 5.5, NaH 2 PO 4 1.8, MgCl, 0.5 and CaCl 2 2.7. KC1 concentration was 3 mmoles/liter in initial experiments and was varied between 2.2 and 8 mmoles/liter in later experiments on conduction time and action potential duration. Bundles of Purkinje fibers (false tendons) were dissected from right and left ventricles and mounted with 576 ROSEN, GELBAND, HOFFMAN stainless steel pins to the wax bottom of a Lucite perfusion chamber designed for these experiments (Fig. 1) . The chamber housed a sloping compartment with a capacity of 4.5 ml. The perfusate entered via two side holes that subdivided into four entry ports, which provided equal perfusion with fresh blood along the entire length of the Purkinje fiber and turbulent flow throughout the chamber. Effluent left through a single port in the deepest part of the chamber. An additional compartment for overflow was provided. Fluid entering this compartment could be channeled to a suction bottle or to the donor animal. Additional entry ports (not depicted in the figure) were included for a thermister and an indifferent electrode.
While the tissues were being mounted in the chamber, Tyrode's solution, equilibrated with a mixture of 95% O 2 -5% CO 2 , was circulated through the chamber with a peristaltic pump (Buchler Instruments Polystaltic pump) and the effluent was channeled to a waste bottle. For blood perfusion, donor dogs were anesthetized with sodium pentobarbital, 30 mg/kg, iv, and given sodium heparin, 3 mg/kg. An additional intravenous injection of heparin, 2 mg/kg, was given every 2 hours. The femoral vessels were cannulated, and arterial blood was pumped into the chamber in place of Tyrode's solution. Blood returning from the chamber was pumped through an air trap and thence to the femoral vein. Flow rates of 12-15 ml/min were maintained, and the blood and Tyrode's solution were kept at 36-37 °C by a glass heat exchanger. The arterial blood pressure of the donor animal was recorded through a Statham pressure gauge attached to the arterial cannula. This signal was transmitted to a carrier amplifier (Tektronix model 3C66) and displayed on an oscilloscope (Tektronix model 564). Electrocardiographs monitoring was accomplished by passing the signal (lead I, II, or III) through a differential amplifier (Tektronix model 3A9) and displaying it on the same oscilloscope.
For these studies, Purkinje fibers mounted in the chamber were stimulated externally through Teflon-coated bipolar silver wire electrodes. Stimulus strength was one to one and a half times threshold, duration was 1-2 msec, and cycle length was varied between 400 and 1000 msec. Action potentials were recorded using glass microelectrodes filled with 3 M KG, with resistances of 10-30 Mohms. The microelectrodes were connected to amplifiers with input impedances of 100 Mohms and input capacity neutralization (Bioelectric Instruments, NF-1) via silver-silver chloride junctions. The methods for recording action potential characteristics and duration, 
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maximal slope of phase 0 of the action potential (Vmax), and membrane responsiveness have been described previously (2, 3) . The depth of the perfusate above the Purkinje fiber surface was less than 1 mm. All data reported were obtained from impalements of single cells maintained during alternate perfusion with blood and Tyrode's solution.
Conduction was studied using two intracellular microelectrodes located approximately 4 mm apart in a free-running Purkinje fiber. The proximal electrode was at least 3 mm from the stimulus site. Conduction time was measured as the interval between the midpoints of the upstrokes of the action potentials recorded through these electrodes. The action potentials were displayed on the two beams of a Tektronix 502 oscilloscope, and the time between the two upstrokes was measured with a digital timer (Monsanto 101A counter-timer) using methods described previously (2) . Changes in conduction were monitored by leading the two traces into a single channel of the 502 and displaying and photographing the differential recording.
Automaticity was studied by stimulating the preparation at a cycle length of 2000 msec until spontaneous activity occurred. At this point the external driving stimulus was discontinued, and, after stabilization of the intrinsic rhythm, spontaneous rate and slope of phase 4 were recorded.
The tissue was equilibrated in Tyrode's solution for 1 hour at the start of each experiment. Subsequent perfusion with blood for 20 minutes permitted changes in electrophysiological properties to occur and fully stabilize. On return to Tyrode's solution a period of 20-30 minutes was required before the measured variables attained stable values. Serum electrolytes (sodium, potassium, chloride, bicarbonate, calcium, and phosphorous) were measured at frequent intervals with a flame photometer or an autoanalyzer in the blood samples taken from the tissue chamber, the arterial cannula of the donor dog, and the venous reservoir bottle. Electrolyte concentrations re-mained stable through the duration of each experiment. To demonstrate the absence of any significant hemolysis, the supernatant fluid of centrifuged blood samples was observed for color changes, and the serum bilirubin and lactic dehydrogenase activity were measured at intervals during the experiment. The oxygen saturation and pH of blood from the arterial cannula and the tissue chamber were determined concurrently with measurements of serum electrolytes using the Astrup technique. No significant differences between donor and chamber blood pH (7.38-7.41) and O 2 saturation (89%-98%) or between blood and Tyrode's solution pH (7.34-7.41) were found.
The possible effect of sodium pentobarbital in the concentrations required for anesthesia of the donor dog on the parameters under study was evaluated in the following way: in two experiments, donor dogs were anesthetized with a-dchloralose, 60 mg/kg. Following the onset of blood perfusion, control determinations were made and then the standard anesthetic dose of pentobarbital (30 mg/kg) was administered to the donor. Immediately after injection there was a transient change in the contour of repolarization. This persisted for 5 minutes and then returned to control by 30 minutes. There was no alteration in action potential amplitude, resting membrane potential, Vmax, action potential duration, or conduction time. Subsequent injection of pentobarbital in doses of 30-120 mg/hour induced no change in action potential properties. In another experiment during perfusion with Tyrode's solution, sodium pentobarbital, 10 mg/liter, failed to alter action potential characteristics (Table 1 ). Since we routinely did not start blood perfusion of the isolated Purkinje fibers until more than 1 hour after induction of pentobarbital anesthesia in the donor and since our evidence suggests that any effect this initial dose of the drug exerts is immediate and transient, we believe that the influence of pentobarbital on action potential characteristics was negligible in the experiments Effect of blood perfusion on action potential charac contrasting perfusion with blood and Tyrode's solution.
Results
Effect of Blood Perfusion on Action Potential Characteristics.-Action potential amplitude, resting membrane potential, action potential duration, and Vmax recorded in Tyrode's solution and blood were compared in 33 experiments. Figure 2 shows records from a typical experiment depicting the transmembrane action potentials of an isolated Purkinje fiber perfused alternately with Tyrode's solution and blood. There were no significant differences in action potential amplitude and resting membrane potential. Action potential duration decreased from 399 msec in Tyrode's solution to 350 msec in blood and the plateau shortened proportionately. There was a concurrent increase in Vmax from 328 to 392 v/sec. The mean values for action potential amplitude, resting membrane potential, action potential duration, and Vmax in blood and Tyrode's solution in 10 experiments at a cycle length of 1000 msec are shown in Table 2 . Note that action potential amplitude and resting membrane potential appeared to be identical in both perfusates. Although action potential duration decreased and Vmax increased during blood perfusion, in comparison to values obtained in Tyrode's solution, the differences were not statistically significant. In 23 additional experiments at cycle lengths of 400-800 msec, results were comparable.
The fact that action potential amplitude and resting membrane potential appear unaltered in Table 2 does not indicate that there Data obtained from ten experiments at a cycle length of 1000 msec. AP amp = action potential amplitude; RMP = resting membrane potential; APD = action potential duration; Vmax = maximal rate of rise of phase 0 of the action potential.
"Calculated according to Fisher (4) . Data from six experiments with the initial reading in Tyrode's solution followed by transfer to blood. Each experiment represents a single impalement at constant cycle length. Cycle length for series 500-800 msec, temperature 36-37°C. was no change in these parameters on transfer from Tyrode's solution to blood. This is shown in Table 3 . Here, in six additional experiments, mean resting membrane potential in Tyrode's solution and blood was -91 mv. Mean action potential amplitude in Tyrode's solution was 124 mv, and in blood it was 123 mv. Despite this similarity of the mean values, it is apparent that in association with changes in [K + ] o , both resting membrane potential and action potential amplitude did change in four instances. In experiment 1 both increased, in experiments 2 and 3 they remained unaltered, and in experiments 4-6 they decreased. These seemingly random variations in resting membrane potential and action potential amplitude may be explained as follows: when resting potential is plotted as a function of [K + ] o , increases in [K + ] o from 4 mmoles/ liter to 5 mmoles/liter or more are invariably associated with decreases in resting membrane potential (5) as seen in experiments 5 and 6. However when [K + ] o is varied within the range of 2 to 5 mmoles/liter, the resting membrane potential of individual Purkinje fibers may increase, decrease, or remain unchanged, as seen in experiments 1-4. Hence, our findings concerning resting membrane potential are in keeping with results obtained previously for isolated cardiac tissues (5, 6) . With regard to action potential amplitude, changes in this parameter probably were due almost entirely to the changes in resting membrane potential.
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The variability in Vmax shown in Table 2 was consistent with the observed changes in action potential amplitude and resting membrane potential. In 29 of 33 impalements, Vmax changed in the same direction as did action potential amplitude and resting membrane potential. The concordance of changes in Vmax with changes in resting membrane potential and action potential amplitude also is seen in Table 3 . In most instances variations in Vmax appear to be directly related to changes in resting membrane potential and action potential amplitude. Where resting membrane potential and action potential amplitude are unchanged (experiments 2 and 3) there is less than a 20-v/sec variation in Vmax; this variability is within the limit of experimental error. The interrelationship between action potential amplitude (reflecting resting membrane potential), Vmax, and perfusate [K + ] is brought out further in Figure 3 . Figure 3 . The subsequent changes in [K + ] o during blood perfusion are the result of a rapid KC1 infusion which may have prevented full equilibration of blood and tissue [K + ] o , thereby explaining the observation that the curves for Tyrode's solution and blood, although of similar configuration, are quantitatively different.
Although the statistical analysis of differences in action potential duration between Tyrode's solution and blood failed to reveal significance, consistent alterations in action potential duration did occur on changing the perfusate from Tyrode's solution to blood. When action potential duration was evaluated as a function of [K + ] o of the perfusion medium a relationship could be found between the two (Fig. 4) Automaticity was studied in nine preparations for which [K + ] in Tyrode's solution and blood differed by less than 1 mmole/liter. The spontaneous rate in blood did not differ significantly from that in Tyrode's solution.
Effect of Blood Perfusion on Membrane Responsiveness.--In four experiments (range of [K + ] was 3 to 4.5 mmoles/liter) the membrane responsiveness curves for Purkinje fibers in blood were compared to those for fibers in Tyrode's solution. Figure 5 depicts results of a representative experiment. Note that the typical S-shaped curve seen during the study in Tyrode's solution is identical to that in blood. Results in the three additional experiments were similar.
Effect of Blood Perfusion on Conduction Time.-Conduction time was measured in 16 experiments. In 13, conduction time in blood was shorter than in Tyrode's solution. Figure 6 shows results from a representative experiment. Conduction time was 1.3 msec in Tyrode's solution and decreased to 1.0 msec in blood.
Initially we thought that a change in [K + ], Vmax, action potential amplitude, or a combination of these might be the basis for changes in conduction time. In Figure 7 , conduction
time is plotted against changes in [K + ] and Vmax, comparing Tyrode's solution and blood. In three experiments [K + ] o in blood and Tyrode's solution was the same, 4 mmoles/liter (left). In one instance transfer from Tyrode's solution to blood perfusion was associated with a decrease in conduction time to 89% of control; in another conduction time remained unchanged at 100%; and in a third experiment conduction time was prolonged to 110%. These changes in conduction were associated with the expected alterations in Vmax. When Vmax increased, conduction was more rapid; when Vmax remained at 100%, conduction was unchanged; and when Vmax decreased, conduction was slowed. Action potential amplitude varied less than 1 mv in the experiments. In the center of Figure 7 Figure 7 , then, the greatest acceleration of conduction was associated with the maximal increment in [K + ] provided that the initial and final concentrations were within the physiological range.
In seven of the nine experiments depicted in the center of Figure 7 , the change in Vmax was associated with the expected accompanying change in action potential amplitude. That is, when Vmax increased so did amplitude, and when Vmax decreased amplitude did the same. However, the transfer from Relationship The right of Figure 7 shows data from four experiments in which [K + ] o of blood was less than that of Tyrode's solution; the transfer from Tyrode's solution to blood was still associated with an acceleration in conduction. In one instance the increase in Vmax was associated with an increase in action potential amplitude. In three instances, however, no correlation between Vmax and amplitude was seen. The transfer to blood following perfusion with Tyrode's solution with [K + ] O = 3.8 and 3.2 mmoles/liter was not associated with alterations in Vmax. In the former, amplitude decreased, in the latter it was unchanged. The transfer to blood following perfusion with Tyrode's solution ([K + ] O = 3.6 mmoles/liter) was associated with decreased Vmax and In 5 of 16 experiments the acceleration of conduction could not be entirely explained on the basis of changes in Vmax or action potential amplitude. It should be apparent from this figure, then, that no simple correlation exists between conduction time and either Vmax, action potential amplitude, or [K + ] in the physiological range.
Effect of Blood Perfusion on Action Potentials of Depressed Fibers and on Abnormal
Conduction.-In several experiments the Purkinje fiber preparations mounted in the tissue chamber were markedly depressed after 30-60 minutes of perfusion with Tyrode's solution: resting membrane potential was low, action potential duration was variable, Vmax was low, and response to electrical stimulation was inconsistent. For such fibers perfusion with blood caused a significant improvement in electrophysiological properties within 1-2 minutes. An example of this is seen in Figure 8 . As shown in A, during perfusion with Tyrode's solution action potential amplitude was 76 mv, resting membrane potential -70 mv, action potential duration 470 msec, and Vmax 52 v/sec. Phase 0 of the action potential was preceded by a long-lasting prepotential and conduction was slow. In B, it is evident that only alternate driving stimuli elicited a response which was propagated to the recording electrode. In C, 90 seconds after onset of blood perfusion action potential amplitude increased to 120 mv, resting membrane potential to -88 mv, Vmax to 300 v/sec, and action potential duration decreased to 390 msec. As shown in D, during blood perfusion every stimulus was followed by a propagated action potential and the prepotential disappeared.
Discussion
The diversity of the components present in blood as compared to Tyrode's solution has complicated the task of determining which components may be responsible for certain of the changes observed in electrophysiological properties. In general, during perfusion with Tyrode's solution, changes in [K + ] o which in-crease resting membrane potential to approximately -90 mv are directly associated with an increase in Vmax (7) . Increases in Vmax, in turn, have been associated with accelerated conduction (8) . Although most results seen during the course of our experiments involving blood perfusion varied in similar fashion to those described for Tyrode's solution and might have been predicted on the basis of prior experimentation in Tyrode's solution, significant variations in one measurement, conduction, did occur in 5 of 16 instances without the anticipated change in related measurements. These differences in results comparing perfusion with Tyrode's solution and blood are best evaluated by looking at some of the specific components of the respective perfusates which may influence electrophysiological properties. The values for pH of the blood and Tyrode's solution were comparable. Of equal importance is the oxygenation. Our major concern in evaluating oxygenation was not to compare perfusate O 2 capacity or saturation but rather to determine whether a critical volume of oxygen essential to maintenance of metabolic requirements was available to the isolated Purkinje fiber in both Tyrode's solution and blood. In their studies of resting canine Purkinje fibers perfused with Tyrode's solution Greenspan and Cranefield (9) determined that the oxygen uptake at 35-38°C was 0.739-1.37 ml O 2 /mg wet weight hour-1 . They further noted that equilibration with 60% O 2 or greater was sufficient to fill this oxygen requirement. Where On concentrations lower than 60& were used, acceleration of the perfusate flow rate from 0.3 to 1.23 ml/hour was sufficient to maintain O2 uptake in the range of 0.739 to 1.37 ml/mg hour" 1 . Although our tissue bath, which is open to the atmosphere, must permit some loss of Po., in Tyrode's solution, our use of 953S O? and a flow rate of 10-15 ml/min probably more than provides the O2 requirement of the tissues even if this is greatly increased by activity. With respect to blood, the oxygen solubility coefficient is such that 0.0226 ml O2 may be dissolved in 1 ml of blood at 37°C and 760 mm Hg (10, p 18) . Considering only the O> physically dissolved in blood, it is apparent that 2.71 ml O 2 /hour (based on 15 ml/min perfusate flow rate and a Po 9 of 100 mm Hg [11] ) could be carried through the tissue chamber. The Purkinje fibers weighed approximately 5 mg; hence, a maximum of 0.54 ml Oe/mg hour" 1 was provided for. This is less than the basic requirement described by Greenspan and Cranefield. However, the figure just presented (0.54 ml CK/mg hour" 1 ) takes into account only the availability of O 2 in solution. Considering the O2 capacity of canine blood (14 ml O 2 /100 ml blood [10, pp 196 and 198] ) and the fact that at least 700 ml of blood passes through the bath per hour, the delivery of O 2 to the tissue bath was many times the predicted (9) uptake. As was stated earlier, the chamber is perfused through four entry ports bringing the oxygenated blood simultaneously to four separate areas along the 1-1.5-cm length of the Purkinje fiber. Hence, in terms of the standards set by Greenspan and Cranefield, the oxygen requirements of the tissues should be provided by our technique.
If one accepts this reasoning concerning the adequacy of tissue oxygenation, it is possible to evaluate the changes noted in action potential characteristics in light of other substances present in blood. First, considering resting membrane potential, maintenance of this variable is felt to depend on the extracellular fluid [K + ] (6) as well as the oxygenation of the perfusion medium (5) . The finding that resting membrane potential was unchanged in both perfusates when [K + ] o was equal supports the argument that the oxygenation of the isolated tissues in both perfusates is comparable. Concerning the relationship of resting membrane potential to [K + ] o , most of our studies were carried out in the potassium concentration range of 2.5 to 5.5 mmoles/liter, and the overall range in any given experiment never exceeded 1.5 mmoles/ liter. Differences in perfusate [K + ] o were reflected in changes in action potential amplitude and resting membrane potential as the perfusate was changed from Tyrode's solution to blood. With [K + ] o greater than 5 mmoles/ Circulation Research, Vol. XXX, May 1972 liter, the largest decreases in resting membrane potential and action potential amplitude were noted (Table 3 ). This is in keeping with the classic measurements of membrane potential and [K + ] o which depict relatively small changes in resting membrane potential with potassium variations in the physiological range and greater changes in resting potential as [K + ] o increases beyond this range (6) . This relationship is illustrated indirectly in Figure 3 where increasing [K + ] o in either Tyrode's solution or blood led to a fall in action potential amplitude. It became apparent throughout our experiments that variations in amplitude were largely due to changes in resting membrane potential, as seen in Table  3 , and hence, by inference, to changes in perfusate [K + ]. Changes in perfusate [Na + ] could exert little effect on amplitude since [Na + ] in Tyrode's solution was always 150 mmoles/liter and in blood was 140-155 mmoles/liter.
The differences seen in Vmax comparing Tyrode's solution and blood could for the most part be explained on the basis of altered resting membrane potential. In 11 of 12 experiments the direction of change in resting potential and Vmax was the same. In 29 of 33 experiments where action potential amplitude and Vmax were compared, the same direction of change in both variables was noted. Hence, the basis for the change in Vmax was the effect of [K + ] o on the membrane potential. Although this explains the direction of change in Vmax, it does not explain the magnitude of change. The question might be asked why, in Table 3 , did a fall of 2 mv in resting membrane potential lead to a decrease of 91 v/sec in Vmax (experiment 4) whereas a fall of 5 mv (experiment 6) led to a decrease of only 45 v/sec. It appears logical that the relationship of change in resting membrane potential to change in Vmax ultimately depends on the voltage level (on the S-shaped curve delineating membrane potential-Vmax relationships) at which the changes under study are occurring. On the steep portion of the curve, a small change in resting potential would cause a large one in Vmax; near the plateau of the curve, however, greater changes in resting potential would affect Vmax less.
Consistent changes in the measurement of action potential duration were noted when comparing experiments in Tyrode's solution and in blood. In Tyrode's solution a decrease in action potential duration is usually due to an increase in [K + ] o , development of hypoxia (5) , or decrease in cycle length (12) . Since cycle length was held constant throughout any given experiment, rate changes could not account for the decrease in action potential duration. If a differing O 2 pressure in Tyrode's solution and blood were the crucial element in determining action potential duration, one would expect a decrease in duration to occur invariably during blood perfusion. This was not the case. Rather, as was demonstrated in Figure 4 , the action potential duration invariably was shorter in that perfusate with the higher [K + ] o -This would indicate that the [K + ] rather than Tyrode's solution or blood per se was the significant factor in determining action potential duration.
The acceleration in conduction that we so frequently demonstrated during blood perfusion was somewhat more difficult to evaluate. In the first place, acceleration often was unassociated with an increase in Vmax. In itself, this is not surprising, since the interrelationship between conduction velocity, voltage, and time is a complex one. Although conduction velocity should decrease as rate of rise of the action potential decreases (13) , changes in fiber diameter, myoplasmic and external resistance, and current density may modify this and hence explain the divergence of the results seen in Figure 7 (left and center). In 7 (left) where [K + ] is constant, conduction velocity varies directly with changes in Vmax. In 7 (center) where blood [K + ] o is greater than that of Tyrode's solution, there is no correlation between changes in conduction and Vmax. It has been shown by Dominguez and Fozzard (14) that small increases in [K + ] o (from 2.7 to 4 mmoles/liter, for instance) are associated with an acceleration of conduction. They state that the basis for an increase in conduction velocity as [K + ] increases within the physiological range is a loss of membrane voltage and a resulting enhancement of excitability. Under these conditions a loss of membrane potential could be associated with a small decrease in Vmax and yet result in acceleration of conduction. In Figure 7 (center) in 7 of the 9 experiments, there was either an increase in Vmax or a decrease in action potential amplitude (reflecting a decrease in resting membrane potential). Either of these changes could explain the acceleration of conduction. In Figure 7 (right) there was no consistent relationship between conduction and [K + ], action potential amplitude, or Vmax in 3 of 4 experiments. Nevertheless, conduction in blood was still faster than in Tyrode's solution. Hence, in 5 of 16 experiments there was a change in neither Vmax nor resting membrane potential association with the acceleration in conduction.
In addition to some change in passive membrane properties, several hypotheses have been considered in seeking an explanation for this phenomenon. First, the catecholamine content of blood may contribute to the acceleration of conduction. However, experimentation has shown that if resting membrane potential initially is greater than -90 mv, catecholamines do not increase the Vmax of the action potential and, hence, will not change conduction (15) . Second, experiments on canine hearts in situ have shown no consistent and significant acceleration of conduction following sympathetic nerve stimulation (16) . Further, our own unpublished observations on infusion of catecholamines during blood perfusion of isolated tissues have demonstrated no change in conduction velocity. Another possible cause for acceleration of conduction would be an increase in threshold potential to a value closer to resting membrane potential during blood perfusion. Such a change might be due to differences in the ionized calcium content in the two perfusates.
It is obvious that our studies of blood as a perfusate for an in vivo-in vitro system have left many questions unanswered. Nevertheless, it is apparent that, compared to Tyrode's solution, blood is a reasonable alternative for perfusion of isolated tissues. In considering any benefits that might be gained by using blood in place of Tyrode's solution, two are immediately apparent: isolated tissues can be studied in a setting more like that present in vivo than is afforded by perfusion with Tyrode's solution, and, similarly, pharmacological studies on electrophysiological properties of single cardiac cells may be observed in a setting that more closely approximates the in vivo milieu.
